SecBot SecBot
SECBOTREPLAY Home › Report › URGN

URGN · Two UroGen Pharma insiders, the Chief Medical Officer and General…

UroGen Pharma Ltd. · CLUSTER filed Sep 9, 2026 at 14:37 ET

At the news

NEUTRALIMPACT 2/10

CLUSTER filed Sep 9, 2026 at 14:37 ET

Two UroGen Pharma insiders, the Chief Medical Officer and General Counsel, sold a combined $102K in open-market shares on September 8, 2026, following non-cash option exercises the prior day. At a $2.1B market cap, the sales represent ~0.005% of market cap, well below the 0.1% threshold for materiality, and the exercise-and-sell pattern is consistent with routine tax-planning or diversification, not a bearish signal. The cluster is neutral, the dollar amount is trivial relative to company size, and the sales are liquidity-driven.

  • CMO Mark Schoenberg sold 871 shares at $42.92 for $37K on 2026-09-08
  • General Counsel Jason Drew Smith sold 1,519 shares at $42.54 for $65K on 2026-09-08
  • Both insiders exercised stock options (non-cash) on 2026-09-07 before selling the next day
  • Total open-market sales: $102K, or ~0.005% of $2.1B market cap

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access